Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Alectinib.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Alectinib.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Alectinib.
Advertisement
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Alectinib.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Alectinib.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Alectinib.
Advertisement
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Alectinib.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Alectinib.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Alectinib.
Advertisement
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Alectinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Alectinib.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Alectinib.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Alectinib.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Alectinib.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Alectinib.
Digoxin
Digoxin may decrease the cardiotoxic activities of Alectinib.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Alectinib.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Alectinib.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Alectinib.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Alectinib.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Alectinib.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Alectinib.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Alectinib.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Alectinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Alectinib.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Alectinib.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Alectinib.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Alectinib.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Alectinib.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Alectinib.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Alectinib.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Alectinib.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Alectinib.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Alectinib.
Vincristine
The excretion of Vincristine can be decreased when combined with Alectinib.
